I recently got an email from my sister about a new drug for macular degeneration eye shots. What I found most surprising and informative about the article is that the Food and Drug Administration has not approved Avastin (what I’m receiving) for macular degeneration shots!
I suppose that could be why my insurance company won’t reimburse for the new glasses I purchased in November of last year. I think it’s time for me to call them again and ask.
Meanwhile my current mantra is: “Never give up! Never surrender!” as Galaxy Quest’s Captain Peter Quincy Taggart would say.
Advertisements
Easy to understand why they pulled the plug on Avasatin – it’s $35 a shot compared to the approved Lucentis which is $2500 a shot. I know I’ve had both. Why should the drug companies make little when they can make much.
I feel so fortunate to be living in a time when something can be done to curtail this vision robber. Thanks for your insight; you give me hope.
Regards,
Sandra Branum